Coleman Mark made three open market purchases of Axsome Therapeutics ($AXSM) shares in the last year, totaling about $200,000, with the most recent on September 8, 2025. This ranks 1,553rd among nearly 5,000 insiders, below the $1.5 million average. He also sold shares four times for $5.1 million, most recently on February 26, 2026, ranking 1,894th out of about 11,700 insiders under the $8.6 million average.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 25000 | $161.11 | 450,996.0000 | 50,412,640 | 5.25% | 0.05% |
| Feb. 23, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Stock Option (Right to Buy) | 6250 | $0.00 | 7,721.0000 | 50,412,640 | 44.74% | 0.01% |
| Feb. 23, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Common Stock | 6250 | $4.95 | 475,996.0000 | 50,412,640 | 1.33% | 0.01% |
| Feb. 20, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Common Stock | 12485 | $4.95 | 469,746.0000 | 50,412,640 | 2.73% | 0.02% |
| Feb. 20, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Stock Option (Right to Buy) | 12485 | $0.00 | 13,971.0000 | 50,412,640 | 47.19% | 0.02% |
| Feb. 10, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Stock Option (Right to Buy) | 5193 | $0.00 | 0.0000 | 50,412,640 | 100.00% | 0.01% |
| Feb. 10, 2026 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Common Stock | 5193 | $8.02 | 457,261.0000 | 50,412,640 | 1.15% | 0.01% |
| Sept. 8, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | P | Common Stock | 488 | $127.40 | 452,068.0000 | 48,765,403 | 0.11% | 0.00% |
| Sept. 8, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | P | Common Stock | 800 | $127.20 | 451,293.0000 | 48,765,403 | 0.18% | 0.00% |
| Sept. 8, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | P | Common Stock | 287 | $127.30 | 451,580.0000 | 48,765,403 | 0.06% | 0.00% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | A | Stock Option (Right to Buy) | 3166 | $0.00 | 3,166.0000 | 48,765,403 | 9999.99% | 0.01% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | A | Restricted Stock Units | 1429 | $0.00 | 1,429.0000 | 48,765,403 | 9999.99% | 0.00% |
| May 27, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 3750 | $105.47 | 454,243.0000 | 48,765,403 | 0.82% | 0.01% |
| May 28, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 3750 | $103.43 | 450,493.0000 | 48,765,403 | 0.83% | 0.01% |
| May 20, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 3000 | $107.49 | 457,993.0000 | 48,765,403 | 0.65% | 0.01% |
| Jan. 3, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Stock Option (Right to Buy) | 9127 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 3, 2025 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Common Stock | 9127 | $9.00 | 460,993.0000 | 0 | 2.02% | 0.00% |
| Nov. 19, 2024 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Stock Option (Right to Buy) | 33410 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 19, 2024 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | M | Common Stock | 33410 | $5.94 | 451,866.0000 | 0 | 7.98% | 0.00% |
| June 7, 2024 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | A | Stock Option (Right to Buy) | 5799 | $0.00 | 5,799.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 5248 | $75.14 | 14,600.0000 | 0 | 26.44% | 0.00% |
| May 28, 2024 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Not found | S | Common Stock | 5249 | $75.21 | 19,848.0000 | 0 | 20.91% | 0.00% |
| Sept. 15, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | M | Common Stock | 11016 | $3.67 | 439,969.0000 | 0 | 2.57% | 0.00% |
| Sept. 15, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | M | Stock Option (Right to Buy) | 11016 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 15, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | S | Common Stock | 18572 | $75.18 | 428,953.0000 | 0 | 4.15% | 0.00% |
| Sept. 15, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | S | Common Stock | 11016 | $75.19 | 428,953.0000 | 0 | 2.50% | 0.00% |
| June 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | A | Stock Option (Right to Buy) | 5681 | $0.00 | 5,681.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | A | Stock Option (Right to Buy) | 2870 | $0.00 | 2,870.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | M | Stock Option (Right to Buy) | 17501 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 3, 2023 | Axsome Therapeutics, Inc. | $AXSM | Coleman Mark | Director | M | Common Stock | 17501 | $1.30 | 447,525.0000 | 0 | 4.07% | 0.00% |